Paperpal Prime Logo

Metabolic Brain Disease : Impact Factor & More

eISSN: 1573-7365pISSN: 0885-7490

Key Metrics

CiteScore
5.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Metabolic Brain Disease

Metabolic Brain Disease Journal Specifications

Overview
Publisher SPRINGER/PLENUM PUBLISHERS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Metabolic Brain Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Metabolic Brain Disease

The protective role of melatonin on the brain in a rat model of Alzheimer's disease.
  • 1 Jul 2026
  • Metabolic brain disease
Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.
  • 1 Jul 2026
  • Metabolic brain disease
Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.
  • 1 Jul 2026
  • Metabolic brain disease
The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.
  • 30 Jun 2026
  • Metabolic brain disease
Gut-brain axis modulation by fecal microbiota transplantation improves dual-organ injury after cerebral ischemia-reperfusion via Caspase-8 dependent inhibition of necroptosis.
  • 29 Jun 2026
  • Metabolic brain disease
Bushen Huoxue Acupuncture alleviates alzheimer's disease progression via the E3 ubiquitin ligase SMURF2‑mediated ubiquitination of LAPTM5.
  • 29 Jun 2026
  • Metabolic brain disease
The protective role of melatonin on the brain in a rat model of Alzheimer's disease.
  • 1 Jul 2026
  • Metabolic brain disease
Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.
  • 1 Jul 2026
  • Metabolic brain disease
Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.
  • 1 Jul 2026
  • Metabolic brain disease
The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.
  • 30 Jun 2026
  • Metabolic brain disease
Gut-brain axis modulation by fecal microbiota transplantation improves dual-organ injury after cerebral ischemia-reperfusion via Caspase-8 dependent inhibition of necroptosis.
  • 29 Jun 2026
  • Metabolic brain disease
Bushen Huoxue Acupuncture alleviates alzheimer's disease progression via the E3 ubiquitin ligase SMURF2‑mediated ubiquitination of LAPTM5.
  • 29 Jun 2026
  • Metabolic brain disease

FAQs on Metabolic Brain Disease